Overbrook Management Corp Champions Oncology, Inc. Transaction History

Overbrook Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$4.0 - $4.67 $21,600 - $25,218	-5,400 Reduced 10.02%	48,488 $194,000
Q3 2022 Nov 10, 2022	SELL	$7.21 - $9.47 $72,100 - $94,700	-10,000 Reduced 15.65%	53,888 $404,000
Q1 2022 May 16, 2022	SELL	$7.26 - $8.53 $127,913 - $150,290	-17,619 Reduced 21.62%	63,888 $519,000
Q3 2021 Nov 12, 2021	SELL	$9.11 - $10.96 $122,374 - $147,225	-13,433 Reduced 14.15%	81,507 $832,000
Q2 2021 Aug 13, 2021	SELL	$8.45 - $11.72 $14,364 - $19,924	-1,700 Reduced 1.76%	94,940 $976,000
Q1 2021 May 17, 2021	SELL	$10.61 - $13.75 $50,981 - $66,068	-4,805 Reduced 4.74%	96,640 $1.09 Million
Q4 2020 Feb 16, 2021	SELL	$8.39 - $13.27 $3,381 - $5,347	-403 Reduced 0.4%	101,445 $1.1 Million
Q3 2020 Nov 16, 2020	SELL	$7.05 - $10.2 $91,093 - $131,794	-12,921 Reduced 11.26%	101,848 $942,000
Q2 2020 Aug 13, 2020	BUY	$6.65 - $9.84 $763,213 - $1.13 Million	114,769 New	114,769 $1.1 Million

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $107M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Overbrook Management Corp, based on Form 13F filings with the SEC.

Stay updated on Overbrook Management Corp with notifications on news.